Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.

Yuko Suzuki,Motoyasu Kan,Gen Kimura,Kumiko Umemoto,Kazuo Watanabe,Mitsuhito Sasaki,Hideaki Takahashi,Yusuke Hashimoto,Hiroshi Imaoka,Izumi Ohno,Shuichi Mitsunaga,Masafumi Ikeda

Journal of gastroenterology（2019）

引用 24|浏览3

暂无评分

摘要

We identified three predictors of the OS in patients with advanced BTC receiving GC therapy in this study, based on which we could classify the patients into three risk groups.

查看译文

关键词

Biliary tract cancer,Chemotherapy,Gemcitabine and cisplatin,Prognostic factor,Validation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要